Detection of JC Virus-Specific Cytotoxic T Lymphocytes in Healthy Individuals
Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from...
Saved in:
Published in | Journal of Virology Vol. 78; no. 18; pp. 10206 - 10210 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Washington, DC
American Society for Microbiology
01.09.2004
|
Subjects | |
Online Access | Get full text |
ISSN | 0022-538X 1098-5514 |
DOI | 10.1128/JVI.78.18.10206-10210.2004 |
Cover
Loading…
Abstract | Article Usage Stats
Services
JVI
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
Spotlights in the Current Issue
JVI
About
JVI
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
JVI
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0022-538X
Online ISSN:
1098-5514
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
JVI
.asm.org, visit:
JVI
|
---|---|
AbstractList | The polyomavirus JC (JCV) infects 85% of healthy individuals, and its reactivation in a limited number of immunosuppressed people causes progressive multifocal leukoencephalopathy (PML), a severe demyelinating disease of the central nervous system. We hypothesized that JCV-specific cytotoxic T lymphocytes (CTLs) might control JCV replication in healthy individuals, blocking the evolution of PML. Using 51Cr release and tetramer staining assays, we show that 8 of 11 HLA-A*0201+ healthy subjects (73%) harbor detectable JCV-specific CD8+ CTLs that recognize one or two epitopes of JCV VP1 protein, the HLA-A*0201-restricted VP1p36 and VPp1100 epitopes. We determined that the frequency of JCV VP1 epitope-specific CTLs varied from less than 1/100,000 to 1/2,494 peripheral blood mononuclear cells. More individuals had JCV VP1-specific than cytomegalovirus-specific CTLs (8 of 11 subjects [73%] versus 2 of 10 subjects [20%], respectively). These results show that a CD8+-T-cell response against JCV is commonly found in immunocompetent people and suggest that these cells might protect against the development of PML.The polyomavirus JC (JCV) infects 85% of healthy individuals, and its reactivation in a limited number of immunosuppressed people causes progressive multifocal leukoencephalopathy (PML), a severe demyelinating disease of the central nervous system. We hypothesized that JCV-specific cytotoxic T lymphocytes (CTLs) might control JCV replication in healthy individuals, blocking the evolution of PML. Using 51Cr release and tetramer staining assays, we show that 8 of 11 HLA-A*0201+ healthy subjects (73%) harbor detectable JCV-specific CD8+ CTLs that recognize one or two epitopes of JCV VP1 protein, the HLA-A*0201-restricted VP1p36 and VPp1100 epitopes. We determined that the frequency of JCV VP1 epitope-specific CTLs varied from less than 1/100,000 to 1/2,494 peripheral blood mononuclear cells. More individuals had JCV VP1-specific than cytomegalovirus-specific CTLs (8 of 11 subjects [73%] versus 2 of 10 subjects [20%], respectively). These results show that a CD8+-T-cell response against JCV is commonly found in immunocompetent people and suggest that these cells might protect against the development of PML. The polyomavirus JC (JCV) infects 85% of healthy individuals, and its reactivation in a limited number of immunosuppressed people causes progressive multifocal leukoencephalopathy (PML), a severe demyelinating disease of the central nervous system. We hypothesized that JCV-specific cytotoxic T lymphocytes (CTLs) might control JCV replication in healthy individuals, blocking the evolution of PML. Using 51 Cr release and tetramer staining assays, we show that 8 of 11 HLA-A*0201 + healthy subjects (73%) harbor detectable JCV-specific CD8 + CTLs that recognize one or two epitopes of JCV VP1 protein, the HLA-A*0201-restricted VP1 p36 and VP1 p100 epitopes. We determined that the frequency of JCV VP1 epitope-specific CTLs varied from less than 1/100,000 to 1/2,494 peripheral blood mononuclear cells. More individuals had JCV VP1-specific than cytomegalovirus-specific CTLs (8 of 11 subjects [73%] versus 2 of 10 subjects [20%], respectively). These results show that a CD8 + -T-cell response against JCV is commonly found in immunocompetent people and suggest that these cells might protect against the development of PML. The polyomavirus JC (JCV) infects 85% of healthy individuals, and its reactivation in a limited number of immunosuppressed people causes progressive multifocal leukoencephalopathy (PML), a severe demyelinating disease of the central nervous system. We hypothesized that JCV-specific cytotoxic T lymphocytes (CTLs) might control JCV replication in healthy individuals, blocking the evolution of PML. Using 51Cr release and tetramer staining assays, we show that 8 of 11 HLA-A*0201+ healthy subjects (73%) harbor detectable JCV-specific CD8+ CTLs that recognize one or two epitopes of JCV VP1 protein, the HLA-A*0201-restricted VP1p36 and VPp1100 epitopes. We determined that the frequency of JCV VP1 epitope-specific CTLs varied from less than 1/100,000 to 1/2,494 peripheral blood mononuclear cells. More individuals had JCV VP1-specific than cytomegalovirus-specific CTLs (8 of 11 subjects [73%] versus 2 of 10 subjects [20%], respectively). These results show that a CD8+-T-cell response against JCV is commonly found in immunocompetent people and suggest that these cells might protect against the development of PML. The polyomavirus JC (JCV) infects 85% of healthy individuals, and its reactivation in a limited number of immunosuppressed people causes progressive multifocal leukoencephalopathy (PML), a severe demyelinating disease of the central nervous system. We hypothesized that JCV-specific cytotoxic T lymphocytes (CTLs) might control JCV replication in healthy individuals, blocking the evolution of PML. Using super(51)Cr release and tetramer staining assays, we show that 8 of 11 HLA-A*0201 super(+) healthy subjects (73%) harbor detectable JCV-specific CD8 super(+) CTLs that recognize one or two epitopes of JCV VP1 protein, the HLA-A*0201-restricted VP1 sub(p36) and VP1 sub(p100) epitopes. We determined that the frequency of JCV VP1 epitope-specific CTLs varied from less than 1/100,000 to 1/2,494 peripheral blood mononuclear cells. More individuals had JCV VP1-specific than cytomegalovirus-specific CTLs (8 of 11 subjects [73%] versus 2 of 10 subjects [20%], respectively). These results show that a CD8 super(+)-T-cell response against JCV is commonly found in immunocompetent people and suggest that these cells might protect against the development of PML. Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy JVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0022-538X Online ISSN: 1098-5514 Copyright © 2014 by the American Society for Microbiology. For an alternate route to JVI .asm.org, visit: JVI |
Author | I. J. Koralnik R. A. Du Pasquier Y. Zheng J. Jean-Jacques N. L. Letvin J. Gordon K. Khalili J. E. Schmitz |
AuthorAffiliation | Division of Viral Pathogenesis, 1 Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, 2 Center for Neurovirology and Cancer Biology, Temple University, Philadelphia, Pennsylvania 3 |
AuthorAffiliation_xml | – name: Division of Viral Pathogenesis, 1 Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, 2 Center for Neurovirology and Cancer Biology, Temple University, Philadelphia, Pennsylvania 3 |
Author_xml | – sequence: 1 givenname: R. A. surname: Du Pasquier fullname: Du Pasquier, R. A. organization: Division of Viral Pathogenesis, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts – sequence: 2 givenname: J. E. surname: Schmitz fullname: Schmitz, J. E. organization: Division of Viral Pathogenesis – sequence: 3 givenname: J. surname: Jean-Jacques fullname: Jean-Jacques, J. organization: Division of Viral Pathogenesis – sequence: 4 givenname: Y. surname: Zheng fullname: Zheng, Y. organization: Division of Viral Pathogenesis – sequence: 5 givenname: J. surname: Gordon fullname: Gordon, J. organization: Center for Neurovirology and Cancer Biology, Temple University, Philadelphia, Pennsylvania – sequence: 6 givenname: K. surname: Khalili fullname: Khalili, K. organization: Center for Neurovirology and Cancer Biology, Temple University, Philadelphia, Pennsylvania – sequence: 7 givenname: N. L. surname: Letvin fullname: Letvin, N. L. organization: Division of Viral Pathogenesis – sequence: 8 givenname: I. J. surname: Koralnik fullname: Koralnik, I. J. organization: Division of Viral Pathogenesis, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16072831$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/15331755$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkV1v0zAUhi00xLrBX0ARCO5S_B0HCQlUGOtUxAVj4s5yHGfxlMTFdgr593PX7gNuQLJsS-d5zzl63yNwMLjBAPACwTlCWLw5u1jOCzFH6UAMeZ7uVMIQ0kdghmApcsYQPQAzCDHOGRE_DsFRCFcQIko5fQIOESMEFYzNwJePJhodrRsy12Rni-zC-jHk39ZG28bqbDFFF93v9DvPVlO_bp2eogmZHbJTo7rYTtlyqO3G1qPqwlPwuEmPebZ_j8H3k0_ni9N89fXzcvFhlWuGYMwxRqqua4NprUvONW8w0phoVVECy0oUGpW0KoyuVcEqkwpKwYZDRjTE1JTkGLzb9V2PVW9qbYboVSfX3vbKT9IpK_-sDLaVl24jky8l3-pf7_Xe_RxNiLK3QZuuU4NxY5Cci2Rpgf8JIgEZK0qYwOcPN7pb5dbpBLzaAypo1TVeDdqGe46ncYKgxL3dcdq7ELxp7hEot_HLFL8sRBotb-KXN_HLbfxJ_P4vsbZRbdNNLtju_1q83LVo7WX7y3ojVejl1cY-FJBrxtbDaw |
CitedBy_id | crossref_primary_10_1002_eji_200939601 crossref_primary_10_1111_j_1468_1331_2011_03597_x crossref_primary_10_1007_s00415_018_9140_0 crossref_primary_10_1007_s13365_016_0432_9 crossref_primary_10_2217_17460794_2_3_255 crossref_primary_10_1128_JVI_79_17_11170_11178_2005 crossref_primary_10_1038_nrd1743 crossref_primary_10_1093_intimm_dxm076 crossref_primary_10_1016_S0035_3787_06_74981_5 crossref_primary_10_1097_01_aids_0000194804_97164_86 crossref_primary_10_1002_ana_20933 crossref_primary_10_1089_apc_2005_19_486 crossref_primary_10_1002_eji_201545632 crossref_primary_10_1016_j_jcyt_2014_04_003 crossref_primary_10_1093_brain_awr206 crossref_primary_10_1002_ana_24471 crossref_primary_10_1212_WNL_0b013e31823b9b27 crossref_primary_10_1016_j_jneuroim_2006_04_003 crossref_primary_10_1002_ccr3_1816 crossref_primary_10_1128_JVI_02803_12 crossref_primary_10_1128_JVI_80_7_3495_3505_2006 crossref_primary_10_1080_1040841X_2016_1189873 crossref_primary_10_1016_j_virol_2006_02_040 crossref_primary_10_3389_fimmu_2014_00646 crossref_primary_10_1097_QAD_0b013e32830a5043 crossref_primary_10_1099_vir_0_82094_0 crossref_primary_10_1016_S1474_4422_10_70040_5 crossref_primary_10_1056_NEJMe058212 crossref_primary_10_2165_11537510_000000000_00000 crossref_primary_10_1016_j_neurol_2014_07_005 crossref_primary_10_1007_s13365_013_0222_6 crossref_primary_10_1016_j_ncl_2008_03_007 crossref_primary_10_1186_1479_5876_10_248 crossref_primary_10_1517_14728222_10_4_489 crossref_primary_10_1099_jmmcr_0_005053 crossref_primary_10_1111_neup_12203 crossref_primary_10_1016_S1474_4422_10_70006_5 crossref_primary_10_1016_j_clineuro_2007_05_009 crossref_primary_10_3390_v12101156 crossref_primary_10_1111_j_1600_6143_2005_00800_x crossref_primary_10_1111_j_0105_2896_2006_00395_x crossref_primary_10_1128_JVI_00614_10 crossref_primary_10_1128_JVI_01809_06 crossref_primary_10_7554_eLife_61056 crossref_primary_10_1056_NEJMe058122 crossref_primary_10_1002_ana_26198 crossref_primary_10_1111_j_1750_3639_2006_00042_x crossref_primary_10_1093_brain_awr268 crossref_primary_10_1111_apm_12128 crossref_primary_10_1016_S1474_4422_10_70124_1 crossref_primary_10_1016_j_jneuroim_2010_09_021 crossref_primary_10_1042_CS20050278 crossref_primary_10_1212_01_wnl_0000257832_38943_2b crossref_primary_10_1016_S1473_3099_09_70226_9 crossref_primary_10_4137_CMT_S4013 crossref_primary_10_1097_QAI_0b013e31825a313c crossref_primary_10_1212_WNL_0b013e3182a84207 crossref_primary_10_1007_s00430_015_0390_5 crossref_primary_10_1007_s10875_021_01205_1 crossref_primary_10_1097_WCO_0b013e3283398c96 crossref_primary_10_1002_art_27687 crossref_primary_10_4161_mabs_1_6_9884 crossref_primary_10_1002_rmv_1866 crossref_primary_10_1016_j_bbmt_2014_03_018 crossref_primary_10_1177_0961203308089445 crossref_primary_10_1111_j_1552_6569_2007_00106_x crossref_primary_10_1080_13550280500513325 |
Cites_doi | 10.1086/514032 10.1080/13550280390195388 10.1128/jvi.70.11.7569-7579.1996 10.1007/BF00375376 10.1097/00002030-200307040-00004 10.1128/JVI.74.17.8140-8150.2000 10.1128/JVI.77.22.11918-11926.2003 10.4049/jimmunol.149.11.3580 10.1182/blood.V90.5.1751 10.1080/13550280152537175 10.1016/S0140-6736(71)91777-6 10.1128/JVI.75.7.3483-3487.2001 10.1080/146532402317251518 10.4049/jimmunol.162.3.1827 10.1084/jem.188.6.1047 10.1006/viro.1996.0424 10.1093/brain/awh215 10.1084/jem.180.4.1283 10.4049/jimmunol.168.1.499 10.1212/WNL.54.3.743 10.1182/blood.V98.3.754 10.4049/jimmunol.167.8.4450 |
ContentType | Journal Article |
Copyright | 2004 INIST-CNRS Copyright 2004 American Society for Microbiology Copyright © 2004, American Society for Microbiology 2004 |
Copyright_xml | – notice: 2004 INIST-CNRS – notice: Copyright 2004 American Society for Microbiology – notice: Copyright © 2004, American Society for Microbiology 2004 |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7T5 7U9 H94 7X8 5PM |
DOI | 10.1128/JVI.78.18.10206-10210.2004 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts Immunology Abstracts Virology and AIDS Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef MEDLINE AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1098-5514 |
EndPage | 10210 |
ExternalDocumentID | PMC514969 15331755 16072831 10_1128_JVI_78_18_10206_10210_2004 jvi_78_18_10206 |
Genre | Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S Journal Article |
GrantInformation_xml | – fundername: NINDS NIH HHS grantid: R01 NS/AI 041198 – fundername: NIAID NIH HHS grantid: P30-AI28691 – fundername: NINDS NIH HHS grantid: NS 047029 – fundername: NINDS NIH HHS grantid: R01 NS047029 – fundername: NIAID NIH HHS grantid: P30 AI028691 – fundername: NINDS NIH HHS grantid: R01 NS041198 |
GroupedDBID | --- -~X .55 .GJ 0R~ 18M 29L 2WC 39C 3O- 4.4 53G 5GY 5RE 5VS 85S AAFWJ AAGFI AAYXX ABPPZ ACGFO ACNCT ADBBV AENEX AFFNX AGVNZ AI. ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW C1A CITATION CS3 DIK E3Z EBS EJD F5P FRP GX1 H13 HYE HZ~ IH2 KQ8 MVM N9A O9- OHT OK1 P2P RHI RNS RPM RSF TR2 UPT VH1 W2D W8F WH7 WOQ X7M Y6R YQT ZGI ~02 ~KM 41~ 6TJ AAYJJ ADXHL D0S IQODW ZXP CGR CUY CVF ECM EIF NPM PKN RHF UCJ 7T5 7U9 H94 7X8 5PM |
ID | FETCH-LOGICAL-c510t-221addde24dc966c6f21c23cab4309b87c194b7ecda75be3caaa0f6053c024e93 |
ISSN | 0022-538X |
IngestDate | Thu Aug 21 18:29:39 EDT 2025 Fri Sep 05 07:12:43 EDT 2025 Fri Sep 05 03:36:39 EDT 2025 Wed Feb 19 01:53:45 EST 2025 Mon Jul 21 09:14:29 EDT 2025 Tue Jul 01 00:56:44 EDT 2025 Thu Apr 24 23:05:43 EDT 2025 Wed May 18 15:31:24 EDT 2016 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 18 |
Keywords | Virus Human Microbiology JC virus Polyomavirus T-Lymphocyte Cytotoxicity Papovaviridae Detection Cytotoxic T lymphocyte Virology |
Language | English |
License | CC BY 4.0 Copyright 2004 American Society for Microbiology |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c510t-221addde24dc966c6f21c23cab4309b87c194b7ecda75be3caaa0f6053c024e93 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 Corresponding author. Mailing address: Division of Viral Pathogenesis and Department of Neurology, Research East, Room 213B, Beth Israel Deaconess Medical Center, 330 Brookline Ave., Boston, MA 02215. Phone: (617) 667-1568. Fax: (617) 667-8210. E-mail: ikoralni@bidmc.harvard.edu. Present address: Division of Neurology and Division of Immunology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland. |
OpenAccessLink | http://doi.org/10.1128/JVI.78.18.10206-10210.2004 |
PMID | 15331755 |
PQID | 18055790 |
PQPubID | 23462 |
PageCount | 5 |
ParticipantIDs | highwire_asm_jvi_78_18_10206 proquest_miscellaneous_66821072 pubmed_primary_15331755 proquest_miscellaneous_18055790 pubmedcentral_primary_oai_pubmedcentral_nih_gov_514969 pascalfrancis_primary_16072831 crossref_primary_10_1128_JVI_78_18_10206_10210_2004 crossref_citationtrail_10_1128_JVI_78_18_10206_10210_2004 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2004-09-01 |
PublicationDateYYYYMMDD | 2004-09-01 |
PublicationDate_xml | – month: 09 year: 2004 text: 2004-09-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Washington, DC |
PublicationPlace_xml | – name: Washington, DC – name: United States |
PublicationTitle | Journal of Virology |
PublicationTitleAlternate | J Virol |
PublicationYear | 2004 |
Publisher | American Society for Microbiology |
Publisher_xml | – name: American Society for Microbiology |
References | e_1_3_2_26_2 (e_1_3_2_23_2) 1999; 162 (e_1_3_2_16_2) 1993; 6 e_1_3_2_20_2 e_1_3_2_21_2 e_1_3_2_22_2 e_1_3_2_24_2 e_1_3_2_25_2 (e_1_3_2_17_2) 1983 (e_1_3_2_19_2) 1992; 149 e_1_3_2_9_2 e_1_3_2_15_2 e_1_3_2_8_2 e_1_3_2_7_2 e_1_3_2_6_2 e_1_3_2_18_2 (e_1_3_2_13_2) 1965; 5470 e_1_3_2_10_2 e_1_3_2_5_2 e_1_3_2_11_2 e_1_3_2_4_2 e_1_3_2_12_2 e_1_3_2_3_2 e_1_3_2_2_2 e_1_3_2_14_2 4104715 - Lancet. 1971 Jun 19;1(7712):1257-60 12824781 - AIDS. 2003 Jul 4;17(10):1443-9 8892876 - J Virol. 1996 Nov;70(11):7569-79 10680816 - Neurology. 2000 Feb 8;54(3):743-6 4284491 - Br Med J. 1965 Nov 6;2(5470):1099-102 3872841 - Immunogenetics. 1985;21(3):235-46 11238876 - J Virol. 2001 Apr;75(7):3483-7 11468176 - Blood. 2001 Aug 1;98(3):754-61 15215217 - Brain. 2004 Sep;127(Pt 9):1970-8 11751998 - J Immunol. 2002 Jan 1;168(1):499-504 9743523 - J Exp Med. 1998 Sep 21;188(6):1047-54 11591771 - J Immunol. 2001 Oct 15;167(8):4450-7 12709872 - J Neurovirol. 2003;9 Suppl 1:47-53 9973448 - J Immunol. 1999 Feb 1;162(3):1827-35 11517410 - J Neurovirol. 2001 Aug;7(4):318-22 11953040 - Cytotherapy. 2002;4(1):41-8 14581528 - J Virol. 2003 Nov;77(22):11918-26 9207375 - J Infect Dis. 1997 Jul;176(1):250-4 8806513 - Virology. 1996 Aug 1;222(1):293-6 1331239 - J Immunol. 1992 Dec 1;149(11):3580-7 8381231 - Mod Pathol. 1993 Jan;6(1):25-32 7523570 - J Exp Med. 1994 Oct 1;180(4):1283-93 9292508 - Blood. 1997 Sep 1;90(5):1751-67 10933725 - J Virol. 2000 Sep;74(17):8140-50 |
References_xml | – ident: e_1_3_2_25_2 doi: 10.1086/514032 – ident: e_1_3_2_2_2 doi: 10.1080/13550280390195388 – volume: 5470 start-page: 1099 year: 1965 ident: e_1_3_2_13_2 publication-title: Br. Med. J. – ident: e_1_3_2_26_2 doi: 10.1128/jvi.70.11.7569-7579.1996 – ident: e_1_3_2_22_2 doi: 10.1007/BF00375376 – ident: e_1_3_2_11_2 doi: 10.1097/00002030-200307040-00004 – ident: e_1_3_2_12_2 doi: 10.1128/JVI.74.17.8140-8150.2000 – ident: e_1_3_2_8_2 doi: 10.1128/JVI.77.22.11918-11926.2003 – volume: 149 start-page: 3580 year: 1992 ident: e_1_3_2_19_2 publication-title: J. Immunol. doi: 10.4049/jimmunol.149.11.3580 – ident: e_1_3_2_6_2 doi: 10.1182/blood.V90.5.1751 – ident: e_1_3_2_7_2 doi: 10.1080/13550280152537175 – ident: e_1_3_2_18_2 doi: 10.1016/S0140-6736(71)91777-6 – ident: e_1_3_2_15_2 doi: 10.1128/JVI.75.7.3483-3487.2001 – ident: e_1_3_2_5_2 doi: 10.1080/146532402317251518 – volume: 162 start-page: 1827 year: 1999 ident: e_1_3_2_23_2 publication-title: J. Immunol. doi: 10.4049/jimmunol.162.3.1827 – ident: e_1_3_2_20_2 doi: 10.1084/jem.188.6.1047 – ident: e_1_3_2_3_2 doi: 10.1006/viro.1996.0424 – volume: 6 start-page: 25 year: 1993 ident: e_1_3_2_16_2 publication-title: Mod. Pathol. – ident: e_1_3_2_9_2 doi: 10.1093/brain/awh215 – ident: e_1_3_2_24_2 doi: 10.1084/jem.180.4.1283 – ident: e_1_3_2_14_2 doi: 10.4049/jimmunol.168.1.499 – ident: e_1_3_2_21_2 doi: 10.1212/WNL.54.3.743 – ident: e_1_3_2_10_2 doi: 10.1182/blood.V98.3.754 – ident: e_1_3_2_4_2 doi: 10.4049/jimmunol.167.8.4450 – start-page: 29 year: 1983 ident: e_1_3_2_17_2 publication-title: Polyomaviruses and human neurological diseases – reference: 14581528 - J Virol. 2003 Nov;77(22):11918-26 – reference: 9973448 - J Immunol. 1999 Feb 1;162(3):1827-35 – reference: 3872841 - Immunogenetics. 1985;21(3):235-46 – reference: 10680816 - Neurology. 2000 Feb 8;54(3):743-6 – reference: 10933725 - J Virol. 2000 Sep;74(17):8140-50 – reference: 1331239 - J Immunol. 1992 Dec 1;149(11):3580-7 – reference: 9207375 - J Infect Dis. 1997 Jul;176(1):250-4 – reference: 11517410 - J Neurovirol. 2001 Aug;7(4):318-22 – reference: 11591771 - J Immunol. 2001 Oct 15;167(8):4450-7 – reference: 8381231 - Mod Pathol. 1993 Jan;6(1):25-32 – reference: 11751998 - J Immunol. 2002 Jan 1;168(1):499-504 – reference: 8892876 - J Virol. 1996 Nov;70(11):7569-79 – reference: 8806513 - Virology. 1996 Aug 1;222(1):293-6 – reference: 9743523 - J Exp Med. 1998 Sep 21;188(6):1047-54 – reference: 11953040 - Cytotherapy. 2002;4(1):41-8 – reference: 9292508 - Blood. 1997 Sep 1;90(5):1751-67 – reference: 12709872 - J Neurovirol. 2003;9 Suppl 1:47-53 – reference: 12824781 - AIDS. 2003 Jul 4;17(10):1443-9 – reference: 15215217 - Brain. 2004 Sep;127(Pt 9):1970-8 – reference: 11468176 - Blood. 2001 Aug 1;98(3):754-61 – reference: 4104715 - Lancet. 1971 Jun 19;1(7712):1257-60 – reference: 4284491 - Br Med J. 1965 Nov 6;2(5470):1099-102 – reference: 7523570 - J Exp Med. 1994 Oct 1;180(4):1283-93 – reference: 11238876 - J Virol. 2001 Apr;75(7):3483-7 |
SSID | ssj0014464 |
Score | 2.0825822 |
Snippet | Article Usage Stats
Services
JVI
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley... The polyomavirus JC (JCV) infects 85% of healthy individuals, and its reactivation in a limited number of immunosuppressed people causes progressive multifocal... |
SourceID | pubmedcentral proquest pubmed pascalfrancis crossref highwire |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 10206 |
SubjectTerms | Adult Biological and medical sciences Cytomegalovirus Cytomegalovirus - immunology DNA-Binding Proteins - immunology Fundamental and applied biological sciences. Psychology HLA-A Antigens - metabolism HLA-A2 Antigen Humans Immunocompetence Immunodominant Epitopes JC virus JC Virus - immunology JC Virus - pathogenicity JC Virus - physiology Leukoencephalopathy, Progressive Multifocal - immunology Leukoencephalopathy, Progressive Multifocal - prevention & control Leukoencephalopathy, Progressive Multifocal - virology Microbiology Miscellaneous Pathogenesis and Immunity Plant Proteins Polyomavirus T-Lymphocytes, Cytotoxic - immunology Trans-Activators Transcription Factors - immunology Virology Virus Replication - immunology |
Title | Detection of JC Virus-Specific Cytotoxic T Lymphocytes in Healthy Individuals |
URI | http://jvi.asm.org/content/78/18/10206.abstract https://www.ncbi.nlm.nih.gov/pubmed/15331755 https://www.proquest.com/docview/18055790 https://www.proquest.com/docview/66821072 https://pubmed.ncbi.nlm.nih.gov/PMC514969 |
Volume | 78 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb5RAFJ6sNSa-GO9Fa-XBtw0r9xkezba1Jdv6IG1WX8gwDFmMBS1gXH-9Z4bLDmY3VhNCCAzDhO_jzDnMuSD0Jk0TN6NY-OGQzHBhCjOSxPcNQhMeZImJU-lNeH7hn1664dJbTiZnitdSUycz9mtrXMn_oArnAFcRJfsPyA6dwgk4BnxhDwjD_lYYH_Gas17lC-fTq_ymqQxZUj7L2XS-rsu6_AlH0XSxBthKtq6lA1YXfbQG8dDHY1U71FQRB6f-eT9qQOusvjd5VzR5YMBHtrrOZXVYJX1nyGlhhJSJ2We0CPV5xVsp82n038EdHKvUOAAQl0tVlmKicoYokhFYYPrKNCtKipvbZbgt4hLCq7MZJjOLzOSdhmwv7fnNzNWv1l98iE8uF4s4Ol5Gd9BdG2O5Yv9-OXj7CKvX7RPHi0F3-WfhWW93P2msq_T5o4X7LK3gC8ra0ifbbJM_XWwVnSV6iB50KOrvWuY8QhNePEb32vKj6yfofOCPXmZ6ONfH_NEH_uiRrvBHzwu944-u8Ocpujw5juanRldew2AgiGvDti2Y3FJuuykDo5f5mW0x22E0cR0zSAhmVuAmmLOUYi_hcIFSMwPz12Gg2PHAeYb2irLg-0jPAi9zvNTi4k0TjyReIDoijFsppZxoKOhfZMy63POiBMrXWNqgNokBhBiT2IJNgBBLEESNVFdDznDvtzYDy63uOujximl1HX_5kastNXQ4wnDTs29i0LgtDb3uQY1B4IpVNFrwsqmgC5G2LjB3t_B9AsPAtoaetyTY9A7GFejrnob8ET2GBiLZ-_hKka9k0ncwbAI_ePHXYb1E9zdf6wHaq28a_gr05jo5lF_Eb-vGvlo |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Detection+of+JC+Virus-Specific+Cytotoxic+T+Lymphocytes+in+Healthy+Individuals&rft.jtitle=Journal+of+virology&rft.au=Du+Pasquier%2C+RA&rft.au=Schmitz%2C+JE&rft.au=Jean-Jacques%2C+J&rft.au=Zheng%2C+Y&rft.date=2004-09-01&rft.issn=0022-538X&rft.volume=78&rft.issue=18&rft.spage=10206&rft.epage=10210&rft_id=info:doi/10.1128%2FJVI.78.18.10206-10210.2004&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-538X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-538X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-538X&client=summon |